Cleveland Clinic researchers have identified biomarkers that might ultimately serve as tools for diagnostics and monitoring — or even as therapeutic targets — in patients with these concurrent conditions.
A Boost for Efforts to Uncover Functional Genomics of Afib
Cleveland Clinic researchers explain how they’ll use a new $3.1 million NHLBI grant to create and manipulate cardiac myocytes to better understand risk variants in genes linked to atrial fibrillation.